Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation on Testosterone in PCOS
NCT06101147Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Sep 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing Vitamin D Group with Placebo Group (2 arms). Primary endpoint: Total Testosterone at 1 year. Started Sep 2023; status: completed.
02
Drugs
vitamin d
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06101147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06101147.